Year |
Citation |
Score |
2018 |
Xu L, Gordon R, Farmer R, Pattanayak A, Binkowski A, Huang X, Avram M, Krishna S, Voll E, Pavese J, Chavez J, Bruce J, Mazar A, Nibbs A, Anderson W, et al. Precision therapeutic targeting of human cancer cell motility. Nature Communications. 9: 2454. PMID 29934502 DOI: 10.1038/S41467-018-04465-5 |
0.791 |
|
2014 |
Khanim F, Davies N, Veliça P, Hayden R, Ride J, Pararasa C, Chong MG, Gunther U, Veerapen N, Winn P, Farmer R, Trivier E, Rigoreau L, Drayson M, Bunce C. Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate. British Journal of Cancer. 110: 1506-16. PMID 24569460 DOI: 10.1038/Bjc.2014.83 |
0.486 |
|
2013 |
Farmer RL, Scheidt KA. A Concise Enantioselective Synthesis and Cytotoxic Evaluation of the Anticancer Rotenoid Deguelin Enabled by a Tandem Knoevenagel/Conjugate Addition/Decarboxylation Sequence. Chemical Science (Royal Society of Chemistry : 2010). 4: 3304-3309. PMID 24101971 DOI: 10.1039/C3Sc50424G |
0.68 |
|
2012 |
Xu L, Farmer R, Huang X, Pruell S, Voll E, Pavese J, Valsecchi M, Biddle M, Nibbs A, Avram M, Scheidt KA, Bergan RC. Abstract 4752: Selective inhibition of cancer metastasis with a novel small therapeutic molecule Cancer Research. 72: 4752-4752. DOI: 10.1158/1538-7445.Am2012-4752 |
0.788 |
|
2012 |
Krishna SN, Luan C, Minasov G, Shuvalova L, Farmer RL, Nibbs A, Scheidt KA, Anderson WF, Bergan RC. Abstract 4751: Structure and inhibition of mitogen-activated protein kinase kinase 4 (MEK4): A prostate cancer pro-invasion protein Cancer Research. 72: 4751-4751. DOI: 10.1158/1538-7445.Am2012-4751 |
0.78 |
|
2011 |
Crane EA, Zabawa TP, Farmer RL, Scheidt KA. Enantioselective synthesis of (-)-exiguolide by iterative stereoselective dioxinone-directed Prins cyclizations. Angewandte Chemie (International Ed. in English). 50: 9112-5. PMID 21932228 DOI: 10.1002/Anie.201102790 |
0.682 |
|
2011 |
Xu L, Farmer R, Huang X, Valsecchi M, Pavese J, Voll E, Biddle M, Nibbs A, Pruell S, Avram M, Scheidt K, Bergan RC. Abstract C177: Chemical-driven biological probing: Discovery of a novel antimetastatic drug. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-C177 |
0.775 |
|
2011 |
Farmer RL, Biddle MM, Nibbs AE, Huang X, Xu L, Bergan RC, Scheidt KA. Erratum: Concise syntheses of the abyssinones and discovery of new inhibitors of prostate cancer and MMP-2 expression (ACS Medicinal Chemistry Letters (2010) 1 (400-405) DOI: 10.1021/ml100110x) Acs Medicinal Chemistry Letters. 2. DOI: 10.1021/Ml1003102 |
0.775 |
|
2010 |
Farmer RL, Biddle MM, Nibbs AE, Huang X, Bergan RC, Scheidt KA. Concise syntheses of the abyssinones and discovery of new inhibitors of prostate cancer and MMP-2 expression. Acs Medicinal Chemistry Letters. 1: 400-405. PMID 21116437 DOI: 10.1021/Ml100110X |
0.771 |
|
2010 |
Pavese JM, Farmer RL, Bergan RC. Inhibition of cancer cell invasion and metastasis by genistein. Cancer Metastasis Reviews. 29: 465-82. PMID 20730632 DOI: 10.1007/S10555-010-9238-Z |
0.613 |
|
2010 |
Xu L, Farmer R, huang x, Pavese J, Voll E, Irene O, Biddle M, Nibbs A, Valsecchi M, Scheidt K, Bergan R. Abstract B58: Discovery of a novel drug KBU2046 that inhibits conversion of human prostate cancer to a metastatic phenotype Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-10-B58 |
0.78 |
|
Show low-probability matches. |